Ilaria Attili

Peripheral Blood Markers Identify Risk of Immune-Related Toxicity in Advanced Non-Small Cell Lung Cancer Treated with Immune-Checkpoint Inhibitors

Alberto Pavan, Lorenzo Calvetti, Alessandro Dal Maso et al. · The Oncologist · 2019 · 224 citations

The role of immune microenvironment in small-cell lung cancer: Distribution of PD-L1 expression and prognostic role of FOXP3-positive tumour infiltrating lymphocytes

Laura Bonanno, Alberto Pavan, Maria Vittoria Dieci et al. · European Journal of Cancer · 2018 · 112 citations

Cancer Immunosurveillance, Immune Microenvironment, Pd-l1 Expression +9

Common Co-activation of AXL and CDCP1 in EGFR-mutation-positive Non-Small Cell Lung Cancer Associated With Poor Prognosis

Niki Karachaliou, Imane Chaib, Andrés F. Cardona et al. · EBioMedicine · 2018 · 77 citations · Full text

Common Co-activation, Medicine, Pathology +9

Role of next generation sequencing-based liquid biopsy in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: impact of STK11, KRAS and TP53 mutations and co-mutations on outcome

Alberto Pavan, Andrea Boscolo Bragadin, Lorenzo Calvetti et al. · Translational Lung Cancer Research · 2021 · 43 citations · Full text

Genomic Characterization of Concurrent Alterations in Non-Small Cell Lung Cancer (NSCLC) Harboring Actionable Mutations

Antonio Passaro, Ilaria Attili, Alessandra Rappa et al. · Cancers · 2021 · 43 citations · Full text